TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
TENX

Tenax Therapeutics Inc

Healthcare · Biotechnology

1.90$ +2.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement TENX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +0.0% -100.0% – – – – – – – – –
– -92.5% +94.8% -28.1% -33.8% +1,090.0% +7.0% -5.0% +4.0% -93.3% – –
– -19.7% -147.9% – – – – – – – – –
– +0.0% +427.6% -90.0% -64.9% +180.1% +31.4% +451.4% -78.6% -40.0% +293.6% +157.1%
– +0.0% -12.9% -9.1% -0.4% -10.1% +4.4% +42.8% -25.1% -11.8% +35.6% +249.5%
– -7.0% +280.7% -82.5% -25.1% +24.1% +14.0% +235.6% -66.2% -25.5% +136.8% +189.2%
– – – – – – – – – – – –
– +0.0% +66,117.8% -100.0% – – – -41.7% +368.2% +439.4% -4.0% -100.0%
– – – – – – – – – – – –
– -65.1% -3,274.0% – – – – +1,192.3% -101.9% – – –
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?